ID   NIAi001-K
AC   CVCL_A8ZS
SY   A18945 LRRK2 K1906M PL2H7; K1906M PL2H7
DR   hPSCreg; NIAi001-K
DR   Wikidata; Q108821040
RX   PubMed=34087985;
CC   From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Lys1906Met (c.5717A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
RX   PubMed=34087985; DOI=10.1016/j.scr.2021.102354; PMCID=PMC8314873;
RA   Beilina A., Langston R.G., Rosen D., Reed X., Cookson M.R.;
RT   "Generation of fourteen isogenic cell lines for Parkinson's
RT   disease-associated leucine-rich repeat kinase (LRRK2).";
RL   Stem Cell Res. 53:102354-102354(2021).
//